Izotropic Corporation (IZO.CN)
CAD 0.04
(-20.0%)
CAD 0.04
(-20.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.03 CAD | 73.64% |
| 2022 | -0.11 CAD | 26.67% |
| 2021 | -0.15 CAD | -7.14% |
| 2020 | -0.14 CAD | -203.69% |
| 2019 | -0.05 CAD | -161.93% |
| 2018 | -0.02 CAD | 45.85% |
| 2017 | -0.03 CAD | -638.64% |
| 2016 | -0.00 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.02 CAD | 0.0% |
| 2023 Q3 | -0.01 CAD | 63.09% |
| 2023 FY | - CAD | 73.64% |
| 2023 Q1 | -0.01 CAD | 68.62% |
| 2023 Q2 | -0.01 CAD | -63.74% |
| 2023 Q4 | - CAD | 100.0% |
| 2022 Q2 | -0.03 CAD | -30.7% |
| 2022 Q1 | -0.02 CAD | 41.89% |
| 2022 FY | - CAD | 26.67% |
| 2022 Q4 | -0.03 CAD | 22.04% |
| 2022 Q3 | -0.04 CAD | -32.38% |
| 2021 Q2 | -0.06 CAD | -106.19% |
| 2021 Q3 | -0.03 CAD | 52.5% |
| 2021 Q4 | -0.04 CAD | -29.82% |
| 2021 FY | - CAD | -7.14% |
| 2021 Q1 | -0.03 CAD | 35.9% |
| 2020 Q2 | -0.01 CAD | 19.33% |
| 2020 FY | - CAD | -203.69% |
| 2020 Q4 | -0.05 CAD | 41.27% |
| 2020 Q3 | -0.08 CAD | -538.84% |
| 2020 Q1 | -0.02 CAD | 26.83% |
| 2019 Q2 | -0.01 CAD | -7.94% |
| 2019 FY | - CAD | -161.93% |
| 2019 Q4 | -0.02 CAD | -95.24% |
| 2019 Q1 | -0.01 CAD | -6.78% |
| 2019 Q3 | -0.01 CAD | -54.41% |
| 2018 Q2 | -0.00 CAD | 2.38% |
| 2018 Q3 | -0.00 CAD | 17.07% |
| 2018 Q4 | -0.01 CAD | -73.53% |
| 2018 FY | - CAD | 45.85% |
| 2018 Q1 | -0.00 CAD | 43.24% |
| 2017 Q3 | -0.00 CAD | 83.68% |
| 2017 Q4 | -0.01 CAD | -138.71% |
| 2017 FY | - CAD | -638.64% |
| 2017 Q1 | -0.00 CAD | 0.0% |
| 2017 Q2 | -0.02 CAD | -442.86% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| BioMark Diagnostics Inc. | -0.02 CAD | -73.653% |
| Sona Nanotech Inc. | -0.03 CAD | 0.344% |